ATI-1777
Phase 1- Indications
- Atopic dermatitis
Company intelligence / Profile preview
Pediatrix Therapeutics
Shanghai, Shanghai, Chinapediatrixtherapeutics.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Pediatrix has successfully conducted bridging PK/PD studies of neffy® intranasal epinephrine in Chinese patients that replicated U.S. results. The company is actively developing ATI‑1777 ("soft" JAK inhibitor) for dermatological conditions under a license from Aclaris. It is also expanding its pipeline through partnerships such as with Tris Pharma for ADHD therapies.
- Therapeutic areas
- PsychiatryImmunology
- Modalities
- Small molecules (e.g., JAK inhibitors)Intranasal formulations (e.g., epinephrine nasal spray)Pediatric-friendly drug formulations
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
ARS Pharmaceuticals – exclusive partner/distributor of neffy® in China/Japan/Australia/NZ.Aclaris Therapeutics – exclusive licensee of ATI‑1777 for Greater China.Tris Pharma – commercializing ADHD portfolio/pipeline products in China.
Beyond the preview
Go deeper on Pediatrix Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pediatrix Therapeutics.